Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

Cited by (1,010)

Items 601–700 of 1,010

1. Evaluation of the Incidence of Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor
   Maiko Inoue, Shinichiro Kobayakawa, Chie Sotozono, Hideki Komori, Kumiko Tanaka, Yuzo Suda, Hiroyuki Matsushima, Shigeru Kinoshita, Tadashi Senoo, Tetsuo Tochikubo et al. · 2011 · Ophthalmologica
2. SHORT-TERM OUTCOMES AFTER INTRAVITREAL INJECTIONS OF CONBERCEPT VERSUS RANIBIZUMAB FOR THE TREATMENT OF RETINOPATHY OF PREMATURITY
   Enzhong Jin, Hong Yin, Xiaoxin Li, Mingwei Zhao · 2017 · Retina
3. A Multinational Comparison of Anti–Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific
   Ravi Parikh, Nathan Pirakitikulr, Jay Kumar Chhablani, Yoichi Sakurada, Rishi P. Singh, Yasha S. Modi · 2018 · Ophthalmology Retina
4. Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models
   Fumiyuki Sasaki, Tomoaki Koga, Mai Ohba, Kazuko Saeki, Toshiaki Okuno, Keijiro Ishikawa, Takahito Nakama, Shintaro Nakao, Shigeo Yoshida, Tatsuro Ishibashi et al. · 2018 · JCI Insight
5. Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization
   Amir Sadeghi, Mahdi Behdani, Serge Muyldermans, Mahdi Habibi‐Anbouhi, Fatemeh Kazemi‐Lomedasht · 2019 · Drug Testing and Analysis
6. Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy
   Archana A. Nair, Avni P. Finn, Paul W. Sternberg · 2022 · Drug Design Development and Therapy
7. Comparative Analysis of Aqueous Humor Cytokine Levels Between Patients With Exudative Age-Related Macular Degeneration and Normal Controls
   Dong Min Cha, Se Joon Woo, Hye Jung Kim, Cheolju Lee, Kyu Hyung Park · 2013 · Investigative Ophthalmology & Visual Science
8. Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
   Adam H. Ross, Paul H. J. Donachie, Ahmed B. Sallam, IRENE M. STRATTON, Quresh Amir Mohamed, Peter H. Scanlon, James N. Kirkpatrick, Robert L. Johnston · 2012 · Eye
9. Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy
   Ahmad A. Aref · 2012 · Current Opinion in Ophthalmology
10. Association of Genetic Polymorphisms with Response to Bevacizumab for Neovascular Age-related Macular Degeneration in the Chinese Population
    Jun Tian, Xueying Qin, Kai Fang, Qing Chen, Jing Hou, Juan Li, Wenzhen Yu, Dafang Chen, Yonghua Hu, Xiaoxin Li · 2012 · Pharmacogenomics
11. An update on the pharmacotherapy of neovascular age-related macular degeneration
    K. Bailey Freund, Sarah Mrejen, Roberto Gallego‐Pinazo · 2013 · Expert Opinion on Pharmacotherapy
12. Detection of aqueous VEGF concentrations before and after intravitreal injection of anti-VEGF antibody using low-volume sampling paper-based ELISA
    Min‐Yen Hsu, Yu‐Chien Hung, De‐Kuang Hwang, Shang-Chi Lin, Keng‐Hung Lin, Chun-Yuan Wang, Hin-Yeung Choi, Yuping Wang, Chao‐Min Cheng · 2016 · Scientific Reports
13. Switching from pro re nata to treat‐and‐extend regimen improves visual acuity in patients with neovascular age‐related macular degeneration
    Line Kvannli, Jørgen Krohn · 2017 · Acta Ophthalmologica
14. Comparative effectiveness and harms of intravitreal antivascular endothelial growth factor agents for three retinal conditions: a systematic review and meta-analysis
    Allison Low, Ambar Faridi, Kavita V. Bhavsar, Glenn C. Cockerham, Michele Freeman, Rochelle Fu, Robin A. Paynter, Karli K. Kondo, Devan L. Kansagara · 2018 · British Journal of Ophthalmology
15. Prefilled syringes for intravitreal drug delivery
    Thérèse M. Sassalos, Yannis Mantas Paulus · 2019 · Clinical ophthalmology
16. Levodopa Positively Affects Neovascular Age-Related Macular Degeneration
    Anna G. Figueroa, Brennan M. Boyd, Cory A. Christensen, Cameron G. Javid, Brian S. McKay, Timothy C. Fagan, Robert W. Snyder · 2020 · The American Journal of Medicine
17. A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes
    Lode, Heidrun Elisabeth, Gjølberg, Torleif Tollefsrud, Foss, Stian, Sivertsen, Magne Sand, Brustugun, Jørgen, Andersson, Yvonne, Jørstad, Øystein Kalsnes, Moe, Morten Carstens, Andersen, Jan Terje · 2019 · Scientific Reports
18. Anti‐vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
    Tsong Qiang Kwong, Moin D. Mohamed · 2014 · British Journal of Clinical Pharmacology
19. FIBROVASCULAR PIGMENT EPITHELIAL DETACHMENT IS A RISK FACTOR FOR LONG-TERM VISUAL DECAY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERETION
    Robert Hoerster, Philipp Sebastian Muether, Vasilena Sitnilska, Bernd Kirchhof, Sascha Fauser · 2014 · Retina
20. Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
    Ilias Zampros, Anna Praidou, PERIKLIS D. BRAZITIKOS, Panagiotis Ekonomidis, Sofia N. Androudi · 2011 · Journal of Ophthalmology
21. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION
    Alexa L. Li, Charles C. Wykoff, Rui Chen Wang, Eric Chen, Matthew S. Benz, Richard H. Fish, Tien P. Wong, James C. Major, David M. Brown, Amy C Schefler et al. · 2015 · Retina
22. Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes
    Douglas MacDonald, Joel H. Martin, Kathir Muthusamy, Jiann-Kae Luo, Erica A. Pyles, Ashique Rafique, Tammy T. Huang, Terra B. Potocky, Yang Liu, Jingtai Cao et al. · 2016 · Angiogenesis
23. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion
    Ingrid Ursula Scott, Paul VanVeldhuisen, Michael S. Ip, Barbara A. Blodi, Neal L. Oden, Jacqueline S. King, Andrew N. Antoszyk, Mark A. Peters, Michael J. Tolentino, for the SCORE2 Investigator Group · 2017 · JAMA Ophthalmology
24. Inhibition of VEGF ‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC 14a
    Taek‐Keun Kim, Chang Sik Park, Jihye Jang, Mi Ra Kim, Hee-Jun Na, Kangseung Lee, Hyun Jung Kim, Kyun Heo, Byong Chul Yoo, Young‐Myeong Kim et al. · 2018 · Molecular Oncology
25. Incidence of Endophthalmitis after Intravitreal Injections: Risk Factors, Microbiology Profile, and Clinical Outcomes
    Chitaranjan Mishra, Prajna Lalitha, Gunasekaran Rameshkumar, Rupesh V. Agrawal, Praveen Kumar Balne, Iswarya Mani, Naresh Babu Kannan, Kim Ramasamy · 2018 · Ocular Immunology and Inflammation
26. Association of Genetic Variants With Response to Anti–Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration
    Laura Lorés‐Motta, Moeen Riaz, Michelle A. Grunin, Jordi Corominas, Freekje van Asten, Marc Pauper, Mathieu Leenders, Andrea Jane Richardson, Philipp Sebastian Muether, Angela Jane Cree et al. · 2018 · JAMA Ophthalmology
27. Spectral-Domain OCT–Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration
    Shamika Gune, Nizar Saleh Abdelfattah, Ayesha Karamat, Siva Balasubramanian, Kenneth M. Marion, Elizabeth A. Morgenthien, Srinivas Reddy Sadda · 2019 · Ophthalmology
28. Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy
    Moo‐Sang Kim, Seung-Chan Lee, Seung-Jun Lee · 2012 · Ophthalmologica
29. Identification of ANGPT2 as a New Gene for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in the Chinese and Japanese Populations
    Li Ma, Marten Erik Brelen, Motokazu Tsujikawa, Haoyu Chen, Wai Kit Chu, Timothy Y. Y. Lai, Danny Siu‐Chun Ng, Kaori Sayanagi, Chicako Hara, Noriyasu Hashida et al. · 2017 · Investigative Ophthalmology & Visual Science
30. Biological, Preclinical and Clinical Characteristics of Inhibitors of Vascular Endothelial Growth Factors
    Victor N. Chong · 2012 · Ophthalmologica
31. Advances in drug delivery to the posterior segment
    William A. Pearce, Jason Hsu, Steven Yeh · 2015 · Current Opinion in Ophthalmology
32. MYOCARDIAL INFARCTION AFTER INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS
    Anna Kemp, David Brian Preen, Nigel Morlet, Antony Clark, Ian L. McAllister, Tom G. Briffa, Frank Mario Sanfilippo, Jonathon Q. Ng, Charlotte M. McKnight, Wayne Reynolds et al. · 2013 · Retina
33. Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel
    H. Gerding, Jordi Monés, Ramin Tadayoni, Francesco Boscia, Ian Pearce, Siegfried Georg Priglinger · 2014 · British Journal of Ophthalmology
34. Predictors of Response to Intravitreal Anti–Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration
    Anjali R. Shah, Steven L. Williams, Caroline R. Baumal, BERNARD A. ROSNER, Jay S. Duker, Johanna M. Seddon · 2015 · American Journal of Ophthalmology
35. Long-term intraocular pressure changes after intravitreal injection of bevacizumab
    Sung Uk Baek, In Won Park, Wool Suh · 2016 · Cutaneous and Ocular Toxicology
36. Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations
    George Kampougeris, Dimitrios Spyropoulos, Adrianna Mitropoulou · 2013 · JOURNAL OF CURRENT GLAUCOMA PRACTICE
37. Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
    Peter K. Kaiser, Michael A. Singer, Michael Tolentino, Robert Vitti, Kristine Erickson, Namrata Saroj, Alyson J. Berliner, Karen W Chu, Xiaoping Zhu, Zinaria Williams Liu et al. · 2017 · Ophthalmology Retina
38. Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular Degeneration
    Philip J. Rosenfeld, Matthew A. Windsor, William J. Feuer, Sissi J.J. Sun, Kevin D. Frick, Eric A. Swanson, David Huang · 2018 · American Journal of Ophthalmology
39. Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months
    Vuong Nguyen, Anagha Vaze, Samantha Fraser‐Bell, Jennifer Arnold, Rohan W. Essex, Daniel Barthelmes, Mark C. Gillies · 2019 · Ophthalmology Retina
40. Animal Models of Choroidal Neovascularization: A Systematic Review
    Bjørn K. Fabian-Jessing, Thomas Stax Jakobsen, Emilie Grarup Jensen, Sidsel Alsing, Silja Hansen, Lars Aagaard, Anne Louise Askou, Toke Bek, Thomas J. Corydon · 2022 · Investigative Ophthalmology & Visual Science
41. Introduction to Clinical Trials
    Lawrence M. Friedman, Curt Daniel Furberg, David L. DeMets, David M. Reboussin, Christopher Bull Granger · 2015 · Springer eBooks
42. Intravitreal Injection Therapy: Current Techniques and Supplemental Services
    Linda A. Lam, Sonia Mehta, Eleonora Maries Lad, Geoffrey G. Emerson, James Michael Jumper, Carl C. Awh, for the Task Force on Intravitreal Injection Supplemental Services · 2021 · Journal of VitreoRetinal Diseases
43. Retinal and Choroidal Vascular Diseases: Past, Present, and Future: The 2021 Proctor Lecture
    Peter A. Campochiaro · 2021 · Investigative Ophthalmology & Visual Science
44. Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development
    Quan Dong Nguyen, Aniruddha Kishandutt Agarwal, William R. Rhoades, Mostafa Hanout, Mohamed Kamel Soliman, Salman Sarwar, Mohammad Ali Sadiq, Yasir Jamal Sepah, V. Diana · 2015 · Clinical ophthalmology
45. Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration
    Moreno Menghini, Barbara Kloeckener‐Gruissem, Johannes C. Fleischhauer, Malaika M. Kurz-Levin, Florian K. P. Sutter, Wolfgang Berger, Daniel Barthelmes · 2012 · PLoS ONE
46. SYSTEMIC BETA-BLOCKERS MAY REDUCE THE NEED FOR REPEATED INTRAVITREAL INJECTIONS IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED BY BEVACIZUMAB
    Javier Antonio Montero, José M. Ruiz‐Moreno, Maria Eugenia Sanchis‐Merino, Santiago Pérez-Martín · 2012 · Retina
47. Long-Term Effects of Multiple Intravitreal Antivascular Endothelial Growth Factor Injections on Intraocular Pressure
    Yoon Jeon Kim, Kyung Rim Sung, Kyoung Sub Lee, Soo Geun Joe, Joo Yong Lee, June-Gone Kim, Young Hee Yoon · 2014 · American Journal of Ophthalmology
48. Evaluation of plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab and aflibercept for exudative age-related macular degeneration
    Izumi Yoshida, Tomoaki Shiba, Hikari Taniguchi, Mao Takahashi, Takeyoshi Murano, Nobuyuki Hiruta, Yuichi Hori, Hdieaki Bujo, Takatoshi Maeno · 2014 · Graefe s Archive for Clinical and Experimental Ophthalmology
49. Stroke Rates after Introduction of Vascular Endothelial Growth Factor Inhibitors for Macular Degeneration: A Time Series Analysis
    Chaim M. Bell, Chaim M. Bell, John Michael Paterson, Susan E. Bronskill, Rahim Moineddin, Marlo Whitehead, Sudeep S. Gill · 2012 · Ophthalmology
50. Anti–Vascular Endothelial Growth Factor Monotherapy in the Treatment of Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
    Han Joo Cho, Kyungmin Koh, Hyoung Seok Kim, Tae Gon Lee, Chul Gu Kim, Jong Woo Kim · 2013 · American Journal of Ophthalmology
51. Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
    Daniel Barthelmes, Anna E. Campain, Phuc Vuong Nguyen, Jennifer Arnold, Ian L. McAllister, Judy M. Simpson, Alex P. Hunyor, Robyn H. Guymer, Rohan W. Essex, Nigel Morlet et al. · 2016 · British Journal of Ophthalmology
52. Management of Retinopathy of Prematurity—Use of Anti-VEGF Therapy
    Kimberly D. Tran, Linda Alejandra Cernichiaro-Espinosa, Audina M. Berrocal · 2017 · Asia-Pacific Journal of Ophthalmology
53. Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina
    Irene Bravo‐Osuna, Vanessa Andrés‐Guerrero, Alicia Arranz-Romera, Sergio Esteban-Pérez, Irene Teresa Molina-Martínez, Rocío Herrero‐Vanrell · 2018 · Advanced Drug Delivery Reviews
54. Quantitative Evaluation of Choroidal Neovascularization under Pro Re Nata Anti–Vascular Endothelial Growth Factor Therapy with OCT Angiography
    Scott M. McClintic, Simon S. Gao, Jie Wang, Ahmed M. Hagag, Andreas Katsuya Lauer, Christina J. Flaxel, Kavita V. Bhavsar, Thomas S. Hwang, David Huang, Yali Jia et al. · 2018 · Ophthalmology Retina
55. Thermal Stimulation of the Retina Reduces Bruch's Membrane Thickness in Age Related Macular Degeneration Mouse Models
    Jan Tode, Elisabeth Richert, Stefan Koinzer, Alexa Klettner, Claus Christian von der Burchard, Ralf Brinkmann, Ralph Lucius, Johann Baptist Roider · 2018 · Translational Vision Science & Technology
56. Apolipoprotein A-I Mimetic Peptide L-4F Removes Bruch's Membrane Lipids in Aged Nonhuman Primates
    Martin Rudolf, Christine A. Curcio, Ursula M. Schlötzer-Schrehardt, Armin Mir Mohi Sefat, Aysegül Tura, Zouhair Aherrahrou, Max Philipp Brinkmann, Salvatore Grisanti, Yoko Miura, Mahdy Ranjbar · 2019 · Investigative Ophthalmology & Visual Science
57. Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
    Marco Pellegrini, Federico Bernabei, Andrea Mercanti, Stefano Sebastiani, Enrico Peiretti, Claudio Iovino, Giamberto Casini, Pasquale Loiudice, Vincenzo Scorcia, Giuseppe Giannaccare · 2020 · Graefe s Archive for Clinical and Experimental Ophthalmology
58. A Method to Enhance Cell Survival on Bruch's Membrane in Eyes Affected by Age and Age-Related Macular Degeneration
    Ilene K. Sugino, Aprille Rapista, Qian Sun, Jianqiu Wang, Celia F. Nunes, Noounanong Cheewatrakoolpong, Marco A. Zarbin · 2011 · Investigative Ophthalmology & Visual Science
59. Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study
    Matamoros, Emilie, Maurel, Frédérique, Léon, Nadia, Solomiac, Agnès, Bardoulat, Isabelle, Joubert, Marc, Hermans, Martine, Moser, Eric, Le Picard, Serge, Souied, Eric H. et al. · 2015 · Ophthalmologica
60. Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial
    Baruch D. Kuppermann, Michaella Goldstein, Raj K. Maturi, Ayala Pollack, Michael A. Singer, Adnan Tufail, Dov Weinberger, Xiaoyan Li, Ching-Chi Liu, Jean Lou et al. · 2015 · Ophthalmologica
61. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia
    Ying Zhu, Ting Zhang, Gezhi Xu, Lijun Peng · 2016 · Cochrane Database of Systematic Reviews
62. CC chemokine receptor-3 as new target for age-related macular degeneration
    Neel Kamal Sharma, Amod Gupta, Sudesh K. Prabhakar, Ramandeep Singh, Arvind Kumar Bhatt, Akshay Anand · 2013 · Gene
63. The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis
    Ruoshuang Zhang, Zheli Liu, Han Zhang, Yi Zhang, Dong Lin · 2016 · PLoS ONE
64. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS
    Julien Tilleul, G. Mimoun, Giuseppe Querques, Nathalie Puche, Jennyfer Zerbib, Franck Lalloum, Mayer Srour, Eric H. Souied · 2015 · Retina
65. Plasma lipoprotein subfraction concentrations are associated with lipid metabolism and age-related macular degeneration
    Chui Ming Gemmy Cheung, Alfred Tau Liang Gan, Qiao Fan, Miao Ling Chee, Rajendra S. Apte, Chiea Chuen Khor, Ian Y. S. Yeo, Ranjana Mathur, Ching‐Yu Cheng, Tien Yin Wong et al. · 2017 · Journal of Lipid Research
66. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications
    Ingrid Ursula Scott, Paul VanVeldhuisen, Michael S. Ip, Barbara A. Blodi, Neal L. Oden, Michael M. Altaweel, Daniel M. Berinstein, for the SCORE2 Investigator Group · 2018 · JAMA Ophthalmology
67. Detection of Reduced Retinal Vessel Density in Eyes with Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Projection-Resolved Optical Coherence Tomography Angiography
    Qi Sheng You, Jie Wang, Yukun Guo, Christina J. Flaxel, Thomas S. Hwang, David Huang, Yali Jia, Steven T. Bailey · 2019 · American Journal of Ophthalmology
68. Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians
    Beau James Fenner, Daniel Shu Wei Ting, Anna C. S. Tan, Kelvin Yi Chong Teo, Choi Mun Chan, Ranjana Mathur, Ian Y. S. Yeo, Tien Yin Wong, Edmund Y. M. Wong, Chui Ming Gemmy Cheung · 2019 · Ophthalmology Retina
69. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide
    Chengyun Wang, Huiyuan Hou, Kaihui Nan, Michael J. Sailor, William R. Freeman, Lingyun Cheng · 2014 · Experimental Eye Research
70. Argon Laser With and Without Anti-Vascular Endothelial Growth Factor Therapy for Extrafoveal Polypoidal Choroidal Vasculopathy
    Chui Ming Gemmy Cheung, Ian Y. S. Yeo, Xiang Li, Ranjana Mathur, Shu Yen Lee, Choi Mun Chan, Doric Wong, Tien Yin Wong · 2012 · American Journal of Ophthalmology
71. The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study
    Hiroshi Tamura, Rei Goto, Yoko Akune, Yoshimune Hiratsuka, Shusuke Hiragi, Masakazu Yamada · 2015 · PLoS ONE
72. Intracellular pathways following uptake of bevacizumab in RPE cells
    Shereen Hassan Aboul Naga, Michaela Dithmer, Guranda Chitadze, Dieter Kabelitz, Ralph Lucius, Johann Baptist Roider, Alexa Klettner · 2014 · Experimental Eye Research
73. Association Between Systemic Hypertension and Macular Thickness Measured by Optical Coherence Tomography
    Mingui Kong, Youngkyo Kwun, Joohon Sung, Don‐Il Ham, Yun‐Mi Song · 2015 · Investigative Ophthalmology & Visual Science
74. Therapies for Neovascular Age-Related Macular Degeneration: Current Approaches and Pharmacologic Agents in Development
    Mostafa Hanout, Daniel Ferraz, Mehreen Ansari, Natasha Maqsood, Saleema Kherani, Yasir Jamal Sepah, Nithya Rajagopalan, Mohamed Ibrahim, V. Diana, Quan Dong Nguyen · 2013 · BioMed Research International
75. Systemic Human CR2-Targeted Complement Alternative Pathway Inhibitor Ameliorates Mouse Laser-Induced Choroidal Neovascularization
    Bärbel Rohrer, Beth A. Coughlin, Mausumi Bandyopadhyay, Vernon Michael Holers · 2012 · Journal of Ocular Pharmacology and Therapeutics
76. Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
    Quan Dong Nguyen, Aniruddha Kishandutt Agarwal, Mohamed Kamel Soliman, Yasir Jamal Sepah, V. Diana · 2014 · Pharmacogenomics and Personalized Medicine
77. Comparison of Optical Coherence Tomography Assessments in the Comparison of Age-Related Macular Degeneration Treatments Trials
    Francisco A. Folgar, Glenn J. Jaffe, Gui‐Shuang Ying, Maureen G. Maguire, Cynthia Ann Toth · 2014 · Ophthalmology
78. One Year Follow-up of Functional Recovery in Neovascular AMD During Monthly Anti-VEGF Treatment
    Marion Ronit Munk, Christopher Kiss, Wolfgang Huf, Florian Sulzbacher, Philipp Ken Roberts, Tamara J. Mittermüller, Stefan Sacu, Christian Simader, Ursula Margarethe Schmidt-Erfurth · 2013 · American Journal of Ophthalmology
79. Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
    Frank Shih-Chang Ong, Jane Zea-Chin Kuo, Wei‐Chi Wu, Ching‐Yu Cheng, Wendell-Lamar B. Blackwell, Brian L. Taylor, Wayne W. Grody, Jerome I. Rotter, Chi‐Chun Lai, Tien Yin Wong · 2013 · Journal of Personalized Medicine
80. Treatment of age-related neovascular macular degeneration: the patient’s perspective
    Sabrina Müller, Christoph Ehlken, Ulrike Bauer-Steinhusen, Werner Lechtenfeld, Zoran Hasanbasic, Hansjuergen Agostini, Thomas Wilke · 2017 · Graefe s Archive for Clinical and Experimental Ophthalmology
81. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration
    Robert F. Mullins, Gerald McGwin, Karen Searcey, Mark E. Clark, Elizabeth L. Kennedy, Christine A. Curcio, Edwin M. Stone, Cynthia J. Owsley · 2018 · Ophthalmology
82. Involvement of TRPV1 and TRPV4 Channels in Retinal Angiogenesis
    Caitriona O'Leary, Mary K. McGahon, Sadaf Ashraf, Jennifer McNaughten, Thomas Friedel, Patrizia Cincolà, Péter Barabás, José A. Fernández, Alan W. Stitt, J. Graham McGeown et al. · 2019 · Investigative Ophthalmology & Visual Science
83. Expression of antibody fragments in Saccharomyces cerevisiae strains evolved for enhanced protein secretion
    Yanyan Wang, Xiaowei Li, Xin Chen, Jens Nielsen, Dina Petranović, Verena Siewers · 2021 · Microbial Cell Factories
84. Macrophage-derived interleukin-6 is necessary and sufficient for choroidal angiogenesis
    Steven Droho, Carla Marie Cuda, Harris Perlman, Jeremy A. Lavine · 2021 · Scientific Reports
85. Common Variant in VEGFA and Response to Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
    Ling Zhao, Seanna Grob, Robert L. Avery, ALAN E. KIMURA, Dante J. Pieramici, J. Lee, Melvin Rabena, Siobhan O. Ortiz, J Quach, Guiqun Cao et al. · 2013 · Current Molecular Medicine
86. Intravitreal ranibizumab for neovascular age-related macular degeneration in clinical practice: five-year treatment outcomes
    Zhu, Meidong, Chew, Jamie K., Broadhead, Geoffrey K., Luo, Kehui, Joachim, Nichole, Hong, Thomas, Syed, Adil, Chang, Andrew A. · 2015 · Graefe's Archive for Clinical and Experimental Ophthalmology
87. Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases
    Noriyasu Hashida, Kohji Nishida · 2023 · Advanced Drug Delivery Reviews
88. Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration
    Pravin U. Dugel, Robert Petrarca, Michael Bennett, Adiel Barak, Dov Weinberger, Jeffrey A. Nau, Timothy L. Jackson · 2012 · Ophthalmology
89. Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up
    Wataru Matsumiya, Shigeru Honda, Sentaro Kusuhara, Yasutomo Tsukahara, Akira Negi · 2013 · BMC Ophthalmology
90. Pharmacokinetics of Ranibizumab after Intravitreal Administration in Patients with Retinal Vein Occlusion or Diabetic Macular Edema
    Yi Xin Zhang, Zhenling Yao, Nitin Kaila, Peter Kuebler, Jennifer E. Visich, Mauricio Maia, Lisa Tuomi, Jason S. Ehrlich, Roman G. Rubio, Peter A. Campochiaro · 2014 · Ophthalmology
91. PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Vaidehi S. Dedania, Seanna Grob, Kang Zhang, Sophie J. Bakri · 2015 · Retina
92. Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis
    Alison Reynolds, Yolanda Álvarez, Temitope Sasore, Nora Waghorne, Clare T. Butler, Claire Kilty, Andrew J. Smith, Carmel McVicar, Vickie H. Y. Wong, Orla Galvin et al. · 2016 · Journal of Biological Chemistry
93. Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration
    Sreekumari Pushpoth, Evripidis Sykakis, Kinnar Merchant, Andrew C. Browning, Rajen Gupta, James Stephen Talks · 2012 · British Journal of Ophthalmology
94. UNTREATED OBSTRUCTIVE SLEEP APNEA HINDERS RESPONSE TO BEVACIZUMAB IN AGE-RELATED MACULAR DEGENERATION
    Shlomit Schaal, Mark P. Sherman, Brooke L. W. Nesmith, Yoreh Barak · 2016 · Retina
95. QUANTITATIVE CHANGES IN RETINAL PIGMENT EPITHELIAL DETACHMENTS AS A PREDICTOR FOR RETREATMENT WITH ANTI-VEGF THERAPY
    Fernando M. Penha, Giovanni Gregori, Carlos Alexandre de Amorim Garcia Filho, Zohar Yehoshua, William J. Feuer, Philip J. Rosenfeld · 2013 · Retina
96. The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: clinical and laboratory evidence
    Qi Zhang, Yun Qi, Li Chen, Xuan Shi, Yujing Bai, Lvzhen Huang, Wenzhen Yu, Yanrong Jiang, Mingwei Zhao, Xiaoxin Li · 2016 · British Journal of Ophthalmology
97. HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Qi Sheng You, Raouf Ahmed Gaber, Amit Meshi, Hema L. Ramkumar, Mostafa Mohamed Ragheb Alam, İlkay Kılıç Müftüoğlu, William R. Freeman · 2017 · Retina
98. Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study
    Georgios Bontzos, Saghar Bagheri, Larissa D Ioannidi, Ivana K. Kim, Ioannis Datseris, Evangelos S. Gragoudas, Stamatina A. Kabanarou, Joan W. Miller, Miltiadis K. Tsilimbaris, Demetrios G. Vavvas · 2019 · Ophthalmology Retina
99. The pattern and gender disparity in global burden of age-related macular degeneration
    Xiling Lin, Lixia Lou, Miao Qi, Yijie Wang, Kai Jin, Peng‐Fei Shan, Yufeng Xu · 2020 · European Journal of Ophthalmology
100. Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration
     Thanh T. Nguyen, Robyn H. Guymer · 2015 · Expert Review of Clinical Pharmacology